In vivo imaging xenograft models for the evaluation of anti-brain tumor efficacy of targeted drugs.

about

In vivo imaging xenograft models for the evaluation of anti-brain tumor efficacy of targeted drugs.

Item

http://www.wikidata.org/entity/Q47136514

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

In vivo imaging xenograft mode ...... or efficacy of targeted drugs.

@en

In vivo imaging xenograft mode ...... or efficacy of targeted drugs.

@nl

type

Item

label

In vivo imaging xenograft mode ...... or efficacy of targeted drugs.

@en

In vivo imaging xenograft mode ...... or efficacy of targeted drugs.

@nl

prefLabel

In vivo imaging xenograft mode ...... or efficacy of targeted drugs.

@en

In vivo imaging xenograft mode ...... or efficacy of targeted drugs.

@nl

P1476

In vivo imaging xenograft mode ...... mor efficacy of targeted drugs

@en

P2093

Akihiro Nishiyama

http://www.w3.org/2001/XMLSchema#string

Kazuo Yasumoto

http://www.w3.org/2001/XMLSchema#string

Koji Fukuda

http://www.w3.org/2001/XMLSchema#string

Mitsutoshi Nakada

http://www.w3.org/2001/XMLSchema#string

Rong Wang

http://www.w3.org/2001/XMLSchema#string

Sachiko Arai

http://www.w3.org/2001/XMLSchema#string

Seiji Yano

http://www.w3.org/2001/XMLSchema#string

Shinji Takeuchi

http://www.w3.org/2001/XMLSchema#string

Tadaaki Yamada

http://www.w3.org/2001/XMLSchema#string

Takashi Murakami

http://www.w3.org/2001/XMLSchema#string

P2860

Targeted Therapy for Brain Metastases in EGFR-Mutated and ALK-Rearranged Non-Small-Cell Lung Cancer

Structure based drug design of crizotinib (PF-02341066), a potent and selective dual inhibitor of mesenchymal-epithelial transition factor (c-MET) kinase and anaplastic lymphoma kinase (ALK)

Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer.

An Oncogenic NTRK Fusion in a Patient with Soft-Tissue Sarcoma with Response to the Tropomyosin-Related Kinase Inhibitor LOXO-101

Novel D761Y and common secondary T790M mutations in epidermal growth factor receptor-mutant lung adenocarcinomas with acquired resistance to kinase inhibitors

A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences

A sequence analysis of the genomic regions involved in the rearrangements between TPM3 and NTRK1 genes producing TRK oncogenes in papillary thyroid carcinomas

Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers

Structure and function of the blood-brain barrier

Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial.

P304

2972-2983

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CAM4.1255

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2017-11-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29125233

http://www.w3.org/2001/XMLSchema#string

P921

xenograft

P932

5727243

http://www.w3.org/2001/XMLSchema#string